NCT04486950View on ClinicalTrials.gov

A Study of TAK-951 in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

July 7, 2020

Primary Completion Date

May 16, 2021

Study Completion Date

May 27, 2021

Conditions

Healthy Volunteer

Interventions

DRUG

TAK-951

TAK-951 intravenous infusion.

DRUG

TAK-951 Placebo

TAK-951 placebo-matching intravenous infusion.

Trial Locations (1)

68502

Celerion, Lincoln

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY